M&A Deal Summary

H2-Phama Acquires Mayne Pharma Group - 15 Mayne Pharma Products

On December 6, 2016, H2-Phama acquired medical products company Mayne Pharma Group - 15 Mayne Pharma Products from Mayne Pharma

Acquisition Highlights
  • This is H2-Phama’s 1st transaction in the Medical Products sector.
  • This is H2-Phama’s 1st transaction in Australia.

M&A Deal Summary

Date 2016-12-06
Target Mayne Pharma Group - 15 Mayne Pharma Products
Sector Medical Products
Buyer(s) H2-Phama
Sellers(s) Mayne Pharma
Deal Type Divestiture

Target

Mayne Pharma Group - 15 Mayne Pharma Products

Salisbury South, Australia
Mayne Pharma Group Ltd.- 15 Mayne Pharma Products is developer and distributor of medical products.

Search 204,714 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

H2-Phama

Montgomery, Alabama, United States

Category Company
Sector Life Science
DESCRIPTION

H2-Phama LLC is a privately-held pharmaceutical company focused on the sales, marketing and development of generic pharmaceuticals.


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (Australia) 1 of 1
Year (2016) 1 of 1

Seller(S) 1

SELLER

Mayne Pharma

Salisbury South, Australia

Category Company
Sector Life Science
Revenue 388M AUD (2024)
DESCRIPTION

Mayne Pharma is a specialty pharmaceutical company that develops and manufactures branded and generic products, which it distributes globally, either directly or through distribution partners and also provides contract development and manufacturing services. Mayne Pharma is based in Salisbury South, Australia.


DEAL STATS #
Overall 1 of 2
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 2
Country (Australia) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-24 Actavis Doryx Brand and Related Assets

United States

Actavis Doryx Brand and Related Assets comprises the Doryx trademark, marketing materials, select product inventory, and related medical and technical data.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-09 Metrics Contract Services

Greenville, North Carolina, United States

Metrics Contract Services is a full-service pharmaceutical development and manufacturing organization serving clients worldwide delivering proven scientific and operational excellence for novel oral dosage forms. Metrics provides formulation development, analytical testing, and commercial manufacturing from its single-campus facility in Greenville, North Carolina.

Sell $475M